Search Results - "Malone, D.C"

ARE NON-RANDOMIZED CONTROLLED STUDIES BEING PUBLISHED IN TOP MEDICAL JOURNALS? by Ip, Q, Malone, D.C

Get full text

Health care utilization and costs by metabolic syndrome risk factors by Boudreau, D M, Malone, D C, Raebel, M A, Fishman, P A, Nichols, G A, Feldstein, A C, Boscoe, A N, Ben-Joseph, R H, Magid, D J, Okamoto, L J

“…This study compared prevalent health utilization and costs for persons with and without metabolic syndrome and investigated the independent associations of the…”
Get more information

Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast Cancer by Gharaibeh, M, Malone, D.C

Get full text

Calculating The Baseline Fracture Incidence In Non-Risk Patients: A Strategy For Cost-Effectiveness Modeling by Nelson, S.D, Malone, D.C, Lafleur, J

Get full text

PMS29 Cost-Effectiveness of Collagenase Clostridium Histolyticum, Limited Fasciectomy, and Percutaneous Needle Fasciotomy in the Treatment of Dupuytren's Contracture by Malone, D.C, Armstrong, E.P

Get full text

Bayesian Analysis of Malformation Outcome in Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy: An Indirect Comparison of Citalopram, Fluoxetine, Paroxetine, and Sertraline by Ip, Q, Smith, K.W, Malone, D.C

Get full text

Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation by Harrington, A.R, Armstrong, E.P, Nolan, P, Malone, D.C

Get full text

Cost-effectiveness analyses for refractory overactive bladder: A systematic literature review by Yehoshua, A, Malone, D.C, Gillard, P, Globe, D

Get full text

PSS2 A Systematic Evaluation of Oral Antibiotic and Isotretinoin Therapies for Moderate to Severe Acne by Armstrong, E.P, Malone, D.C, Cognata Smith, C

Get full text

PHP64 The Incidence of Potential Drug-Drug Interactions Originating From the Same Prescriber by Malone, D.C, Hines, L.E, Brown, S, Warholak, T.L

Get full text

PIH1 The Clinical Consequences of Exposure to Clinically Important Drug-Drug Interactions by Malone, D.C, Hines, L.E, Brown, S

Get full text

PUK18 Cost-Effectiveness of Pharmacologic Treatment of Overactive Bladder by Malone, D.C, Armstrong, E.P, Bui, C

Get full text

PUK8 Nocturia and the Risk of Falls, Fractures, and Sleep Disturbance: a Systematic Review and Meta-Analysis by Tsai, K, Globe, D, Malone, D.C

Get full text

PHP85 Evaluation of Prescriber Perceptions of a Near-Real Time Fax Alert Program for Potential Drug-Drug Interactions by Armstrong, E.P, Malone, D.C, Hines, L.E, Wang, S.M, Patel, B.V

Get full text

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population by Saverno, K, Malone, D.C, Warholak, T.L, Armstrong, E.P, Slack, M

Get full text

Impact Of Medicare Part D Coverage On Health Outcomes In End-Stage Renal Disease by Park, H, Rascati, K.L, Lawson, K.A, Barner, J, Richards, K, Malone, D.C

Get full text

PRM31 Assessment of Adoption of United States Prescribing Guidelines for Dabigatran in a Real World Population by Schrader, B.J, Charland, S.L, Malone, D.C, Agatep, B.C, Herrera, V, Hawk, G.S, Stanek, E.J

Get full text

PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment by Malone, D.C, Charland, S.L, Agatep, B.C, Herrera, V, Hawk, G.S, Schrader, B.J, Stanek, E.J

Get full text

MO3 Cost-Effectiveness Analysis of Different Strategies for Fragility Fracture Prevention in United States Male Veterans by Lafleur, J, Nelson, R.E, Adler, R.A, Nebeker, J.R, Nelson, S, Smith, J, Malone, D.C

Get full text

Healthcare resource burden of newly diagnosed epilepsy in the US low-income elderly population by Tang, D.H, Malone, D.C, Warholak, T.L, Chong, J, Armstrong, E.P, Slack, M.K, Hsu, C.-H, Labiner, D.M

“…Abstract Objective To assess the incremental and relative healthcare resource burden of new-onset epilepsy among the concurrently old and medically indigent…”
Get full text